| | english | español | français |
Go to record ID

  Home|Finding Information|Record details   Printer-friendly version

Modified Organism
Potato resistant to aminoglycoside antibiotics
Record information and status
Record ID
Date of creation
2012-02-20 13:51 UTC (german_bch@bvl.bund.de)
Date of last update
2012-08-24 20:21 UTC (dina.abdelhakim@cbd.int)
Date of publication
2012-08-24 20:21 UTC (dina.abdelhakim@cbd.int)

This document is also available in the following languages:
Living Modified Organism identity
The image below identifies the LMO through its unique identifier, trade name and a link to this page of the BCH. Click on it to download a larger image on your computer. For help on how to use it go to the LMO quick-links page.

LMO name
Potato resistant to aminoglycoside antibiotics
Transformation event
potato (Solanum tuberosum, variety Albatros) 35S-nptII
Universität Rostock
Agrobiotechnology - Faculty of Agricultural and Environmental Sciences
Justus-von-Liebig-Weg 6

Rostock, Mecklenburg-Vorpommern
Germany, 18059
Phone:+49 381 498 ext 3080
Fax:+49 381 498 ext 3082
Url:Rostock University,Agrobiotechnology - Rostock University
This transgenic potato, variety Albatros, is resistent towards aminoglycoside antibiotics such as kanamycin, neomycin and geneticin. Such potatos are meant to be cultivated as control plants in field trials with differently genetically modified potato plants.  
Recipient Organism or Parental Organisms
The term Recipient organism refers to an organism (either already modified or non-modified) that was subjected to genetic modification, whereas Parental organisms refers to those that were involved in cross breeding or cell fusion.
Solanum tuberosum - Potato, SOLTU
Characteristics of the transformation process
plant transformation vector 35S, derivate of pLH9000
Techniques used for the modification
  • Agrobacterium-mediated DNA transfer
Genetic elements construct
CaMV 35S promoter
0.00 Kb
Neomycin Phosphotransferase II
0.00 Kb
CaMV 35S terminator
0.00 Kb
Further details
Notes regarding the genetic elements introduced or modified in this LMO
The LMO 35S-nptII expresses the nptII gene which confers resistance towards aminoglycoside antibiotics. The nptII gene is put under the control of the CaMV 35S promoter and -terminator.
LMO characteristics
Modified traits
Common use(s)
  • Research
Detection method(s)
Additional information
PCR-based methods, to be developed on the information about the transformation vector

Records referencing this document (2)
2record(s) found
Country's Decision or any other Communication1 record
Risk Assessment1 record